Markus Smolny
Papers
1
Total Citations
47
H-Index
1
About
Markus Smolny is a leading figure in bioprocess engineering and pharmaceutical formulation, with a specialized focus on the high-throughput development of therapeutic antibodies. His most influential work centers on revolutionizing the traditionally labor-intensive process of antibody formulation through automation and robotic systems. In his landmark 2009 paper, "Formulation Development of Antibodies Using Robotic System and High-Throughput Laboratory (HTL)," which has garnered 47 citations, Smolny demonstrated how integrating robotic liquid handling with miniaturized analytical assays can dramatically accelerate the screening of buffer conditions, excipients, and stabilizers. This contribution provided a foundational framework for the industry’s shift toward automation, enabling faster identification of stable, manufacturable antibody formulations while reducing material consumption. By bridging the gap between laboratory research and commercial production, Smolny’s work has directly impacted the efficiency of drug development pipelines, particularly for monoclonal antibodies. His achievements highlight a career dedicated to merging engineering principles with biological sciences, making him a key reference for researchers seeking to implement high-throughput methodologies in biopharmaceutical process development.
Research Focus
Key Achievements
Top Papers
- 1